Results 151 to 160 of about 85,647 (239)

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)

Respirology, Volume 31, Issue 2, Page 135-140, February 2026.
David M. G. Halpin, Refiloe Masekela, Claus F. Vogelmeier, Obianuju B. Ozoh, Alvaro A. Cruz, Helen K. Reddel, Arzu Yorgancıoğlu, Alvar Agusti, on behalf of the Boards of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA), Alvar Agusti, Bartolome R. Celli, Gerard Criner, David Halpin, Maria Montes de Oca, Obianuju B. Ozoh, Sundeep Salvi, Claus Vogelmeier, Jinping Zheng, Arzu Yorgancioglu, Keith Allan, Guy Brusselle, Muhwa Jeremiah Chakaya, Alvaro A. Cruz, Hiromasa Inoue, Jerry A. Krishnan, Mark L. Levy, Helen K. Reddel   +26 more
wiley   +1 more source

The dual-site agonist for human M2 muscarinic receptors Iper-8-naphtalimide induces mitochondrial dysfunction in <i>Saccharomyces cerevisiae</i>. [PDF]

Microb Cell
Cirigliano A, Amelina A, Passarini E, Ricelli A, Balasco N, Mori M, Botta B, De Stefano ME, Papotto C, Guerriero C, Tata AM, Rinaldi T.   +11 more
europepmc   +1 more source

Long-acting β₂ agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β₂ adrenergic receptor tachyphylaxis. [PDF]

Respir Res
Jude J, Karmacharya N, Sherpa RT, O'Riordan TG, Koziol-White CJ, Panettieri RAJ.   +5 more
europepmc   +1 more source

Selective modulation of murine intestinal M₁ and M₃ muscarinic receptor expression has divergent effects on specialized epithelial cells and body weight. [PDF]

Am J Physiol Cell Physiol
Sampaio Moura N, Schledwitz A, Cheng K, Song Y, Kwon MS, Cairns CA, Njei LP, Raufman B, Drachenberg CB, Wang JY, Ma B, Raufman JP.   +11 more
europepmc   +1 more source

Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline-Trospium Chloride) for Managing Psychotic Symptoms in Patients With Schizophrenia and Alzheimer's Disease. [PDF]

Brain Behav
Kanwal A, Azeem B, Nasir H, Mumtaz F, Ashraf N, Amin MHJ, Kanwal W, Khan BW.   +7 more
europepmc   +1 more source

Synergistic mechanisms of medullary cholinergic-serotonergic pathway interactions in regulating neuronal excitability and locomotor activities. [PDF]

Commun Biol
Cheng Y, Dai Y, Ge R, Zhang Q.
europepmc   +1 more source

From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia? [PDF]

J Int Med Res
Golden JC, Murphy KS, Tampi RR.
europepmc   +1 more source

The pharmacology underlying the unique antipsychotic efficacy of clozapine. [PDF]

J Psychopharmacol
Reynolds GP.
europepmc   +1 more source

Activity-dependent muscarinic signalling regulates presynaptic PKC pathway and neurotransmission machinery at the neuromuscular junction. [PDF]

Cell Commun Signal
Polishchuk A, Just-Borràs L, Cilleros-Mañé V, Balanyà-Segura M, Silvera Simón C, Tomàs M, Jami El Hirchi M, Díaz-Wallach M, Hurtado E, Tomàs J, Lanuza MA.   +10 more
europepmc   +1 more source